Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that frequently infects wounds, significantly impairs wound healing, and causes morbidity and mortality in burn patients. Here, we report the genome sequence of a virulent strain of P. aeruginosa, 12-4-4(59), isolated from the blood culture of a burn patient.
GENOME ANNOUNCEMENT
Pseudomonas aeruginosa, a highly motile, Gram-negative bacterium, is the primary cause of morbidity in clinical burn wound sepsis (1–5). This organism also causes lethal septicemia with its virulence and invasive nature that enables the dissemination from the surface of the burned skin into deeper layers via hair follicles and lymphatic channels, resulting a fatal burn wound sepsis (3, 6, 7).
Strain 12-4-4(59) was isolated from the blood culture of a deceased burn patient with septicemia following second and third degree burn trauma over 70 per cent of her body (8). Rat skin burn wounds infected with 12-4-4(59) had high rates (95.5 per cent) of mortality (3, 8). This strain was extensively used previously at the U.S. Army, Institute of Surgical Research (Fort Sam Houston, Texas) as an infective pathogen in a rat model of burn infection, for development of therapeutic agents to prevent burn wound sepsis. These studies led to the highly successful clinical use of Sulfamylon cream as an effective topical treatment to prevent septicemia in burn patients (3, 8, 9).
To determine the mechanisms underlying the virulent nature of the 12-4-4(59) isolate, the genome was sequenced. De novo genome sequencing service was provided by BGI Tech Solutions Co., Ltd. (Cambridge, MA, USA) using a hybrid sequencing approach on two sequencing platforms—the Illumina HiSeq 4000 and the PacBio RS II systems. This approach generated a high-quality close-circular final assembly of 6,431,911 bp in size. The sequence was annotated by the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (PGAP) (10), which generated the following: 5,912 genes, 5,802 coding sequences (CDS), 35 pseudogenes, 12 rRNAs including 4 copies of 5S, 16S, and 23S rRNA each, 35 tRNAs, and 1 noncoding RNA (ncRNA) The genome sequence presented here will be a valuable resource to better understand pathogenome evolution of P. aeruginosa 12-4-4-(59) by comparing this pathogenic isolate to the extant genotypes. Moreover, availability of multiple genomes of P. aeruginosa will aid in the development of a higher-resolution framework for deciphering the virulence mechanisms and pathophysiology of P. aeruginosa.
Nucleotide sequence accession number.
This genome sequence is deposited in GenBank under the accession number CP013696.
ACKNOWLEDGEMENTS
This work was supported by the U.S. Army Medical Research and Materiel Command, Combat Casualty Care Research Directorate and the Research Associateship Program from the National Research Council (S.L.R.K.).
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
Footnotes
Citation Karna SLR, Chen T, Chen P, Peacock TJ, Abercrombie JJ, Leung KP. 2016. Genome sequence of a virulent Pseudomonas aeruginosa strain, 12-4-4(59), isolated from the blood culture of a burn patient. Genome Announc 4(2):e00079-16. doi:10.1128/genomeA.00079-16.
REFERENCES
- 1.Keen EF III, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, Murray CK. 2010. Incidence and bacteriology of burn infections at a military burn center. Burns 36:461–468. doi: 10.1016/j.burns.2009.10.012. [DOI] [PubMed] [Google Scholar]
- 2.Keen EF III, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, Murray CK. 2010. Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns 36:819–825. doi: 10.1016/j.burns.2009.10.013. [DOI] [PubMed] [Google Scholar]
- 3.Lindberg RB, Moncrief JA, Mason AD Jr.. 1968. Control of experimental and clinical burn wounds sepsis by topical application of sulfamylon compounds. Ann NY Acad Sci 150:950–960. doi: 10.1111/j.1749-6632.1968.tb14747.x. [DOI] [PubMed] [Google Scholar]
- 4.Rezaei E, Safari H, Naderinasab M, Aliakbarian H. 2011. Common pathogens in burn wound and changes in their drug sensitivity. Burns 37:805–807. [DOI] [PubMed] [Google Scholar]
- 5.Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M. 2014. Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet 10:e1004518. doi: 10.1371/journal.pgen.1004518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kirketerp-Møller K, Jensen PØ, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Høiby N, Givskov M, Bjarnsholt T. 2008. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46:2717–2722. doi: 10.1128/JCM.00501-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rabin ER, Graber CD, Vogel EH Jr, Finkelstein RA, Tumbusch WA. 1961. Fatal pseudomonas infection in burned patients. A clinical, bacteriologic and anatomic study. N Engl J Med 265:1225–1231. doi: 10.1056/NEJM196112212652501. [DOI] [PubMed] [Google Scholar]
- 8.Walker HL, Mason AD Jr, Gilbert raulston LC. 1964. Surface infection with Pseudomonas aeruginosa. Ann Surg 160:297–305. doi: 10.1097/00000658-196408000-00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lindberg RB, Moncrief JA, Mason AD, Brame RE. 1964. Prevention of invasive Pseudomonas aeruginosa infections in seeded burned rats by use of topical sulfamylon cream. Fed Proc 23:388. [Google Scholar]
- 10.Angiuoli SV, Gussman A, Klimke W, Cochrane G, Field D, Garrity G, Kodira CD, Kyrpides N, Madupu R, Markowitz V, Tatusova T, Thomson N, White O. 2008. Toward an online repository of standard operating procedures (SOPs) for (meta)genomic annotation. Omics 12:137–141. doi: 10.1089/omi.2008.0017. [DOI] [PMC free article] [PubMed] [Google Scholar]